Search research articles
Contact Us
Filters
Showing results (51-60 of 77) with videos related to
Page
of 8
Sort By:
International Clinical Psychopharmacology
|
April 1, 1989
A double-blind comparison of fluoxetine, imipramine and placebo in outpatients with major depression
J P Feighner, W F Boyer, C H Merideth, et al.
The Journal of Clinical Psychiatry
|
June 1, 1990
Adverse consequences of fluoxetine-MAOI combination therapy
J P Feighner, W F Boyer, D L Tyler, et al.
Acta Psychiatrica Scandinavica
|
August 1, 1982
A double blind comparison of lofepramine, imipramine and placebo in patients with depression
J P Feighner, C H Meridith, J E Dutt, et al.
The American Journal of Psychiatry
|
April 1, 1972
Hormonal potentiation of imipramine and ECT in primary depression
J P Feighner, L J King, M A Schuckit, et al.
Journal of Clinical Psychopharmacology
|
December 1, 1994
Venlafaxine for treatment-resistant unipolar depression
A A Nierenberg, J P Feighner, R Rudolph, et al.
Acta Psychiatrica Scandinavica
|
October 1, 1983
A double-blind comparison of alprazolam vs. imipramine and placebo in the treatment of major depressive disorder
J P Feighner, C H Meredith, N R Frost, et al.
Psychopharmacology Bulletin
|
January 1, 1988
Pilot study of alpidem, a novel imidazopyridine compound, in anxiety
S F Langer, J p Feighner, R Pambakian, et al.
The American Journal of Psychiatry
|
April 1, 1984
A double-blind study of bupropion and placebo in depression
J P Feighner, C H Meredith, W C Stern, et al.
Psychopharmacology Bulletin
|
January 1, 1989
A comparison of nefazodone, imipramine, and placebo in patients with moderate to severe depression
J P Feighner, R Pambakian, R C Fowler, et al.
JAMA
|
June 10, 1983
Comparison of alprazolam, imipramine, and placebo in the treatment of depression
J P Feighner, G C Aden, L F Fabre, et al.
Page
of 8
Search research articles
Search
Showing results (51-60 of 77) with videos related to
Sort By:
Page
of 8
International Clinical Psychopharmacology
|
April 1, 1989
A double-blind comparison of fluoxetine, imipramine and placebo in outpatients with major depression
J P Feighner, W F Boyer, C H Merideth, et al.
The Journal of Clinical Psychiatry
|
June 1, 1990
Adverse consequences of fluoxetine-MAOI combination therapy
J P Feighner, W F Boyer, D L Tyler, et al.
Acta Psychiatrica Scandinavica
|
August 1, 1982
A double blind comparison of lofepramine, imipramine and placebo in patients with depression
J P Feighner, C H Meridith, J E Dutt, et al.
The American Journal of Psychiatry
|
April 1, 1972
Hormonal potentiation of imipramine and ECT in primary depression
J P Feighner, L J King, M A Schuckit, et al.
Journal of Clinical Psychopharmacology
|
December 1, 1994
Venlafaxine for treatment-resistant unipolar depression
A A Nierenberg, J P Feighner, R Rudolph, et al.
Acta Psychiatrica Scandinavica
|
October 1, 1983
A double-blind comparison of alprazolam vs. imipramine and placebo in the treatment of major depressive disorder
J P Feighner, C H Meredith, N R Frost, et al.
Psychopharmacology Bulletin
|
January 1, 1988
Pilot study of alpidem, a novel imidazopyridine compound, in anxiety
S F Langer, J p Feighner, R Pambakian, et al.
The American Journal of Psychiatry
|
April 1, 1984
A double-blind study of bupropion and placebo in depression
J P Feighner, C H Meredith, W C Stern, et al.
Psychopharmacology Bulletin
|
January 1, 1989
A comparison of nefazodone, imipramine, and placebo in patients with moderate to severe depression
J P Feighner, R Pambakian, R C Fowler, et al.
JAMA
|
June 10, 1983
Comparison of alprazolam, imipramine, and placebo in the treatment of depression
J P Feighner, G C Aden, L F Fabre, et al.
Page
of 8